Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

June 1, 2015

Study Completion Date

February 29, 2016

Conditions
Dental Prophylaxis and Implant Surgery
Interventions
DRUG

0.2% w/v Chlorhexidine digluconate

Participants will brush their teeth with the reference product (toothpaste) and thoroughly rinse their mouth with water and wait 5 timed minutes before using 10 ml of the 0.2% w/v Chlorhexidine digluconate mouthwash, except when using at site, where no brushing will take place prior to using the mouthrinse.

DRUG

Sodium fluoride toothpaste (Aquafresh Mild & Minty)

Participants will apply a strip of toothpaste to cover the head of the toothbrush and will brush in their usual manner for two timed minutes twice daily. They will then rinse their mouth thoroughly with water after brushing

Trial Locations (1)

WC1X 8LD

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02319668 - Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity | Biotech Hunter | Biotech Hunter